| SHORT COMMUNICATION |
|
| Year : 2011 | Volume
: 43
| Issue : 1 | Page : 69-72 |
A double-blind, randomized, multicentric, placebo-controlled clinical trial of antarth, a phytomedicine, in the treatment of osteoarthritis
Anil K Gupta1, Kirankumar Acharya2, Parag S Sancheti3, Ramchandra S Joshi4
1 Department of Orthopaedics, G.S.V.M. Medical College, Kanpur - 208 002, Uttar Pradesh, India
2 Department of Orthopaedics, K.G. Medical College and Hospital, Manipal - 576 104, Karnataka, India
3 Sancheti Institute for Orthopaedics and Rehabilitation, 16, Shivaji Nagar, Pune - 411 005, Maharashtra, India
4 14 Shiv Shanti, Juhu Versova Link Road, Andheri (west), Mumbai - 400 053, Maharashtra, India
Correspondence Address:
Anil K Gupta
Department of Orthopaedics, G.S.V.M. Medical College, Kanpur - 208 002, Uttar Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0253-7613.75674
Objective : To test Antarth, a polyherbal phytomedicine, for its efficacy and safety in patients with osteoarthritis (OA) and compared with placebo.
Material and Methods : A total of 90 male or female adult patients who were diagnosed clinically and radiologically with OA were recruited in the study. Antarth or placebo was given 2 capsules b.i.d. for 3 months and the patients were assessed every month for its efficacy. Diclofenac sodium was allowed to be taken as rescue medication.
Results : After 3 months of treatment, the reduction in severity of pain on Visual Analog Scale (VAS) was more in Antarth group compared to placebo but the difference between the two groups was not significant. However, pain during functioning of disabled joints while walking distance, squatting, sitting cross-legged and climbing steps were significantly reduced in Antarth group compared to placebo (P < 0.05). Reduction in consumption of rescue medication, diclofenac sodium, was more in Antarth than in placebo group.
Conclusions : In Patients' Global Assessment, patients treated with Antarth were more satisfied than the ones treated with placebo. Observations were similar in Physicians' Global Assessment too. There were no adverse events in both the groups.
[FULL TEXT] [PDF]*
|
